AKT1 and diabetes mellitus: The CS coating significantly improved the impaired biological performance of titanium induced by diabetes through ROS-mediated PI3K/AKT pathway reactivation, providing a novel surface functionalization strategy to improve the clinical performance of titanium prosthesis in diabetic patients.